Table 3

Secondary outcomes—STI linked to high-risk behaviour, referral to health advisors, indications for emergency contraception

Secondary outcomesPAPICAPICASI
N (%)OR (95% CI)N (%)OR* (95% CI)N (%)OR* (95% CI)
1. STI targeted by enhanced screen45 (5.8)143 (5.8)1.01 (0.65 to 1.57)37 (4.7)0.74 (0.46 to 1.16)
2. HIV test uptake540 (69.3)1512 (68.8)0.98 (0.78 to 1.21)498 (62.6)0.73 (0.59 to 0.90)
3. HBV test uptake127 (16.3)1180 (24.2)1.65 (1.28 to 2.13)134 (16.9)1.02 (0.78 to 1.33)
4. HCV test uptake22 (2.8)166 (8.9)3.36 (2.05 to 5.51)26 (3.3)1.17 (0.66 to 2.09)
5. Rectal sample taken104 (13.4)1124 (16.7)1.35 (1.00 to 1.82)113 (14.2)1.01 (0.75 to 1.37)
6. Possible indicator for EC (women only)49 (12.1)165 (16.9)1.49 (1.00 to 2.22)90 (22.6)2.14 (1.46 to 3.13)
7. Health advisor§ attendance119 (15.3)1103 (13.8)0.89 (0.67 to 1.19)99 (12.5)0.80 (0.60 to 1.06)
  • * OR relative to pen and paper interview (PAPI) arm, adjusted for patient gender and recruitment clinic.

  • Hepatitis B virus (HBV), hepatitis C virus (HCV), rectal gonorrhoea, rectal chlamydia.

  • Unprotected vaginal sex in last week, or emergency contraception (EC) given as reason for attendance.

  • § The health advisor role includes counselling for safer sexual behaviour and partner notification.

  • CAPI, computed-assisted personal interview; CASI, computer-assisted self-interview; STI, sexually transmitted infection.